Skip to main content
Ephraim Fuchs, MD, Oncology, Baltimore, MD

EphraimJosephFuchsMDM.B.A.

Oncology Baltimore, MD

Hematologic Oncology

Professor of Oncology, Johns Hopkins University School of Medicine; Associate Professor of Oncology

Dr. Fuchs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fuchs' full profile

Already have an account?

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-8964

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1991 - 1994
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1988 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell Transplantation  
    Leo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature

Press Mentions

  • The Bone-Marrow-Transplant Revolution
    The Bone-Marrow-Transplant RevolutionApril 23rd, 2024

Grant Support

  • Restoring T Cell Responses To Therapeutic Tumor VaccinesNational Cancer Institute2005–2009
  • Transplantation Of CD8+ T Cell-Depleted Peripheral Blood CellsNational Center For Research Resources2007
  • Allogeneic Lymphocyte Infusions To Treat Myeloid CancersNational Cancer Institute2006–2007
  • A Pilot Protocol To Determine The Effects Of Osmolar Stress In The ColonNational Center For Research Resources2006
  • Allogenic Graft Versus Tumor EffectNational Cancer Institute2001–2002
  • Immunotherapy Of Acute Lymphocytic LeukemiaNational Cancer Institute1996–1999
  • Activation Requirements Of Mature CD8+ T CellsNational Institute Of Allergy And Infectious Diseases1994–1996
  • Immunotherapy Of Acute Lymphocytic LeukemiaNational Cancer Institute1995